Soluble tumor necrosis factor receptor in serum of patients with arthritis

Journal of the Formosan Medical Association

Volumn 96, Issue 8, 1997, Pages 573-578

  Lee, Chyou Shen ^a,b   Chen, Kung Heng ^b   Wang, Pe Cheng ^c  

^a Sect Allerg Immunol Rheumatology   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL CENTRAL UNIVERSITY   (Taiwan)

Author keywords

Gout; Osteoarthritis; Rheumatoid arthritis; Soluble growth factor receptor; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTHRITIS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GOUT; HUMAN; MAJOR CLINICAL STUDY; OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; SERUM;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; HUMANS; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030860370     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Old LJ: Tumor necrosis factor (TNF). Science 1985;230:630-2.
2. Beutler B, Cerami A: The biology of cachectin/TNF-α primary mediator of the host response. Annu Rev Immunol 1989;7:625-55.
3. Perlmutter DH, Dinarello CA, Punsal PI, et al: Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest 1986;78: 1349-54.
4. Brennan FM, Field M, Chu CQ, et al: Cytokine expression in rheumatoid arthritis. J Rheumatol 1991;30:76-80.
5. Brennan FM, Chantry D, Jackson A, et al: Inhibitory effect of TNF-α antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989;ii:244-7.
6. Van Damme J, Opdenakker G, Simpson RJ, et al: Identification of the human 26-kD protein, Interferon β2 (INF-β2), as a B cell hybridoma/plasmacytoma growth factor induced by in terleukin-1 and tumor necrosis factor. J Exp Med 1987;165:914-9.
7. Seelentag WK, Mermod JJ, Montesano R, et al: Additive effects of interleukin-1 and tumor necrosis factor alpha on the accumulation of the three granulocyte and macrophage colony-stimulating factor mRNAs in human endothelial cells. EMBO J 1987;6:2261-6.
8. Strieter RW, Kunkel SL, Showell HJ, et al: Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS and IL-1β. Science 1989;243:1467-9.
9. Dayer JM, Bentler B, Cerami A: Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985;162:163-8.
10. Henderson B, Pettipher ER: Arthritogenic actions of recombinant IL-1 and tumor necrosis factor a in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol 1989;75:306-10.
11. Osborn L, Hession C, Tizard R, et al: Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989;59:1203-11.
12. Gamble JR, Harlan JM, Klebanoff SJ, et al: Stimulation of the adherence of neutrophils to umbilical endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 1985;82:8667-71.
13. Vilevek J, Palombella VJ, Henriksen-Destefano D, et al: Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med 1986;163:632-43.
14. Saklatvala J: Tumor necrosis factor α stimulates resorption and inhibits systhesis of proteoglycan in cartilage. Nature 1986;322:547-9.
15. Bertolini DR, Nedwin GE, Bringman TS, et al: Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factor. Nature 1986;319:516.
16. Haworth C, Brennan FM, Chantry D, et al: Expression of granulocyte-macrophage colony stimulation factor (GM-CSF) in RA: regulation by TNF-α. Eur J Immunol 1991; 21:2575-9.
17. Taga T, Kishimote T: Cytokine receptors and signal transduction. FASEB J 1992;6:3387-96.
18. Brockhaus M, Schoefield HJ, Schlaeger EJ, et al: Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 1990;87:3127-31.
19. Tartuglia LA, Goeddel DV: Two TNF receptors. Immunol Today 1992;13:151-3.
20. Eriksen BK, Smeland EB, Blomhoff HK, et al: Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes. Eur J Immunol 1991;21:1033-7.
21. Seckinger P, Isaaz S, Dayer JM: Purification and biological characterization of a specific tumor necrosis factor α inhibitor. J Biol Chem 1989;264:11966-73.
22. Dayer JM, Fenner H: The role of cytokines and their inhibitors in arthritis. Baillieres Clin Rheumatol 1992;6:485-516.
23. Aderka D, Engelmann H, Shemer-Avni Y, et al: Variations in the levels of soluble TNF receptors among healthy individuals. Lymphokine Cytokine Res 1992;11:157-9.
24. Aderka DH, Engelmann V, Hornik Y, et al: Increased serum levels of soluble receptor for tumor necrosis factor in cancer patients. Cancer Res 1991;51:5602-7.
25. Cope AP, Maini RN: Soluble TNF receptors in arthritis. J Rheumatol 1995;22:382-4.
26. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 Revised Criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
27. Barrera P, Boerbooms AM, Janssen EM, et al: Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis: longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis Rheum 1993;36:1070-9.
28. Girardin E, Roux-Lombard P: Imbalance between tumor necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcemia. Immunology 1992;76:20-3.
29. Di Giovine FS, Nuki G, Duff GW: Tumor necrosis factor in synovial exudates. Ann Rheum Dis 1988;47:768-72.